OSE Immunotherapeutics SA (OSE.PA)
EUR 5.72
(1.15%)
EUR 5.72
(1.15%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.18 EUR | -22.92% |
| 2022 | -0.96 EUR | -3.23% |
| 2021 | -0.93 EUR | 12.26% |
| 2020 | -1.06 EUR | -241.94% |
| 2019 | -0.31 EUR | -188.57% |
| 2018 | 0.35 EUR | 147.95% |
| 2017 | -0.73 EUR | -144.24% |
| 2016 | 1.65 EUR | 379.66% |
| 2015 | -0.59 EUR | -63.89% |
| 2014 | -0.36 EUR | -997.56% |
| 2013 | -0.03 EUR | 81.78% |
| 2012 | -0.18 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 2.63 EUR | 0.0% |
| 2023 Q2 | -0.64 EUR | 0.0% |
| 2023 Q4 | -0.54 EUR | 0.0% |
| 2023 FY | - EUR | -22.92% |
| 2022 Q2 | -0.11 EUR | 0.0% |
| 2022 Q4 | -0.86 EUR | 0.0% |
| 2022 FY | - EUR | -3.23% |
| 2021 FY | - EUR | 12.26% |
| 2021 Q4 | -0.29 EUR | 0.0% |
| 2021 Q2 | -0.64 EUR | 0.0% |
| 2020 Q4 | -0.84 EUR | 0.0% |
| 2020 FY | - EUR | -241.94% |
| 2020 Q2 | -0.21 EUR | 0.0% |
| 2019 Q4 | -0.35 EUR | 0.0% |
| 2019 Q2 | 0.03 EUR | 0.0% |
| 2019 FY | - EUR | -188.57% |
| 2018 FY | - EUR | 147.95% |
| 2018 Q2 | 0.57 EUR | 0.0% |
| 2018 Q4 | -0.23 EUR | 0.0% |
| 2017 FY | - EUR | -144.24% |
| 2017 Q4 | -0.29 EUR | 0.0% |
| 2017 Q2 | -0.44 EUR | 0.0% |
| 2016 FY | - EUR | 379.66% |
| 2016 Q4 | -0.25 EUR | 0.0% |
| 2016 Q2 | 2.10 EUR | 0.0% |
| 2015 FY | - EUR | -63.89% |
| 2015 Q4 | -0.27 EUR | 0.0% |
| 2015 Q2 | -0.32 EUR | 0.0% |
| 2014 FY | - EUR | -997.56% |
| 2014 Q4 | -0.27 EUR | 0.0% |
| 2014 Q2 | -0.09 EUR | 0.0% |
| 2013 Q1 | -0.01 EUR | 0.0% |
| 2013 Q2 | -0.02 EUR | -146.91% |
| 2013 Q3 | -0.01 EUR | 58.5% |
| 2013 FY | - EUR | 81.78% |
| 2013 Q4 | -0.02 EUR | -100.0% |
| 2012 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -883.333% |
| ABIVAX Société Anonyme | -3.43 EUR | 65.598% |
| Adocia SA | -1.91 EUR | 38.22% |
| Aelis Farma SA | -0.39 EUR | -202.564% |
| Biophytis S.A. | -12.55 EUR | 90.598% |
| Advicenne S.A. | -0.67 EUR | -76.119% |
| genOway Société anonyme | 0.17 EUR | 794.118% |
| IntegraGen SA | -0.03 EUR | -4455.985% |
| Medesis Pharma S.A. | -0.80 EUR | -47.5% |
| Neovacs S.A. | -0.00 EUR | -47100.0% |
| NFL Biosciences SA | -0.46 EUR | -156.522% |
| Plant Advanced Technologies SA | 0.07 EUR | 1785.714% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -1196.703% |
| Sensorion SA | -0.17 EUR | -594.118% |
| Theranexus Société Anonyme | -0.88 EUR | -34.091% |
| TME Pharma N.V. | -1.34 EUR | 11.94% |
| Valbiotis SA | -0.59 EUR | -100.0% |
| TheraVet SA | -0.49 EUR | -140.816% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -686.667% |
| DBV Technologies S.A. | -0.71 EUR | -66.197% |
| Genfit S.A. | -0.58 EUR | -103.448% |
| GeNeuro SA | -0.59 EUR | -100.0% |
| Innate Pharma S.A. | -0.09 EUR | -1153.985% |
| Inventiva S.A. | -2.43 EUR | 51.44% |
| MaaT Pharma SA | -1.73 EUR | 31.792% |
| MedinCell S.A. | -0.88 EUR | -34.091% |
| Nanobiotix S.A. | -1.08 EUR | -9.259% |
| Poxel S.A. | -0.91 EUR | -29.67% |
| GenSight Biologics S.A. | -0.54 EUR | -118.519% |
| Transgene SA | -0.22 EUR | -436.364% |
| Valneva SE | -0.73 EUR | -61.644% |